Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebro

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

In this CME article, get a better understanding of bleeding risk associated with use of serotonin reuptake inhibitors (SRIs) and review research-informed literature on related bleeding complications in patients with cardiovascular and cerebrovascular disease.

Related Keywords

United States , Boston , Massachusetts , Philadelphia , Pennsylvania , Rochester , New York , Delaware , Duke University Medical Center , North Carolina , Nambi , Western Australia , Australia , California , Sydney , New South Wales , Berlin , Germany , Houston , Texas , Westmead , Dover , Melbourne , Victoria , Bilker , Nordrhein Westfalen , American , Ann Pharmacother , Sris Ssris , Clin Neurosci , Gen Thorac Cardiovasc , Ssris Snris , Richard Balon , Johnj Miller , Los Angeles , Florey Institute Of Neuroscience , American College Of Cardiology , Department Of Consultation , Moffitt Cancer Center , American Heart Association , University Of Texas Md Anderson Cancer Center , Northern New England Cardiovascular Disease Study Group , Accreditation Council For Continuing Medical Education , National Institute Of Health , Bayhealth Medical Center , University Of Melbourne , National Comorbidity Survey Replication , University Of California , Mental Health , Philadelphia College Of Osteopathic Medicine , Accreditation Council , Continuing Medical Education , Physician Education Resource , Psychiatric Times , Education Resource , Reuptake Inhibitors , Bleeding Risk , Practical Review , Consultation Psychiatrist , Cerebrovascular Disease , Associated Bleeding Categorized , National Institute , Care Excellence , American College , Ventricular Assist , Internal Medicine , Duke University Medical , Westmead Hospital , Concord Repatriation General Hospital , Australia Dr Gleasonis , Consultation Liaison Psychiatry , Florey Institute , Australia Dr Keyis , Austin Dell Medical School , Florida Dr Choprais , Cancer Center , Integrative Oncology , California Dr Fonsecais , Mayo Clinic , Minnesota Dr Amonoois , Philadelphia College , Osteopathic Medicine , Wilmot Cancer Centre , Rochester Medical Center , National Comorbidity Survey , March Gen , Occup Environ , Cardiovasc Pharmacol , Database Syst , Accessed July , Thorac Cardiovasc , New England Cardiovascular Disease Study , Pharmacoepidemiol Drug , Heart Lung , Bleeding , Tssri , Cardiovascular , Major Depressive Disorder , Depression , Cme ,

© 2025 Vimarsana